Drug-Eluting Stents Unlikely To Dramatically Reduce CABG Demand – ECRI
This article was originally published in The Gray Sheet
Executive Summary
Increased use of drug-eluting stents will not significantly erode the number of coronary artery bypass surgeries (CABG) performed, according to an ECRI technology assessment